Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/29/2012 | CN101297977B Biological adhesive agent and use thereof |
02/29/2012 | CN101288653B Methylphenidate hydrochloride sustained-release floating micropill in stomach and its preparation method |
02/29/2012 | CN101287708B Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
02/29/2012 | CN101287483B Pharmaceutical compositions and methods for accelerating wound healing |
02/29/2012 | CN101279081B Chinese medicine for improving microcirculation and immunity of human body and processing method |
02/29/2012 | CN101273995B Method for preparing magnetic particles modified by afi-tiazin dyes |
02/29/2012 | CN101268063B Thiophene derivatives for the treatment of diabetes |
02/29/2012 | CN101253270B Prophylactic/ameliorating agent for menopausal disorder and functional beverage/food |
02/29/2012 | CN101244051B Actarit cyclodextrin, clathrate compound of cyclodextrin derivant and preparation thereof |
02/29/2012 | CN101239151B Chinese medicine for preventing and controlling cardiovascular and cerebrovascular diseases and preparation method thereof |
02/29/2012 | CN101208328B Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
02/29/2012 | CN101185642B Glucosamine lysine selenium salt and production process |
02/29/2012 | CN101133144B Method for producing a raw oil from mixtures of micro-organisms and plants, oil produced according to said method and specific uses of the thus produced oil and refined oil from the produced oil |
02/29/2012 | CN101128417B Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride |
02/29/2012 | CN101125855B Method for separating hemporfin isomer and separated isomer |
02/29/2012 | CN101119740B Use of radix sanguisorbae and its extract for preparing medicament to increase RBC and hemoglobin |
02/29/2012 | CN101060838B Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
02/28/2012 | US8124794 Method for the asymmetric synthesis of beta-lactone compounds |
02/28/2012 | US8124788 Spirocyclic cyclohexane compounds with analgesic activity |
02/28/2012 | US8124778 Tricyclic inhibitors of fatty acid amide hydrolase |
02/28/2012 | US8124776 Process and intermediates for preparing arzoxifene |
02/28/2012 | US8124773 1,8-naphthyridine compounds for the treatment of cancer |
02/28/2012 | US8124772 Intermediate products for producing oxazolidinone-quinolone hybrids |
02/28/2012 | US8124759 Inhibitors of protein kinases |
02/28/2012 | US8124753 Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene |
02/28/2012 | US8124728 CA125 gene and its use for diagnostic and therapeutic interventions |
02/28/2012 | US8124657 Metallofullerols and their applications for preparation of medicine for inhibition of tumor growth |
02/28/2012 | US8124656 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
02/28/2012 | US8124655 Use of LR-90 and LR-102 to overcome insulin resistance |
02/28/2012 | US8124654 Derivatives of hypoestoxide and related compounds |
02/28/2012 | US8124653 Controlled, sustained and/or time release tetrahydrobiopterin formulations; phenylketonuria; optionally with methylphenidate, clonidine, amphetamine and/or pemoline |
02/28/2012 | US8124652 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
02/28/2012 | US8124651 Palmarumycin based inhibitors of thioredoxin and methods of using same |
02/28/2012 | US8124650 Antitumor combinations containing taxane derivatives and epidophyllotoxins |
02/28/2012 | US8124649 Oxindole compounds |
02/28/2012 | US8124648 Therapeutic lactams |
02/28/2012 | US8124647 Non-steroidal androgens compounds |
02/28/2012 | US8124646 Substituted isoindoline-1,3-dione derivatives |
02/28/2012 | US8124645 LPA receptor antagonist |
02/28/2012 | US8124644 Carvedilol phosphate |
02/28/2012 | US8124643 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
02/28/2012 | US8124641 Aminotetrahydroindazoloacetic acids |
02/28/2012 | US8124640 non-film-coated tablets comprising a mixture of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride, microcrystalline cellulose, lubricants, colloidal silica and lactose, having stability |
02/28/2012 | US8124639 Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors |
02/28/2012 | US8124638 Tricyclic compounds useful as angiotensin II agonists |
02/28/2012 | US8124637 Anthra [1, 2-d]imidazole-6,11-dione derivatives, preparation method and application thereof |
02/28/2012 | US8124636 Imidazolidinone derivatives as 11B-HSD1 inhibitors |
02/28/2012 | US8124634 CB1 receptor modulators |
02/28/2012 | US8124633 Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists |
02/28/2012 | US8124632 Alkylsulfonyl-substituted thiazolide compounds |
02/28/2012 | US8124631 Use of quaternary pyridinium salts as vasoprotective agents |
02/28/2012 | US8124630 ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
02/28/2012 | US8124629 Naphthylacetic acids |
02/28/2012 | US8124628 Diaryl substituted alkanes |
02/28/2012 | US8124627 Biphenyl compounds useful as muscarinic receptor antagonists |
02/28/2012 | US8124626 Methods of treating inflammations and infections with pyridinium salts |
02/28/2012 | US8124625 Method of enhancing the expression of apolipoprotein AI using olefin derivatives |
02/28/2012 | US8124624 Substituted sulfonamide compounds |
02/28/2012 | US8124623 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials |
02/28/2012 | US8124622 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
02/28/2012 | US8124621 Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them |
02/28/2012 | US8124620 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
02/28/2012 | US8124619 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
02/28/2012 | US8124618 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
02/28/2012 | US8124617 Imidazopyridine compounds |
02/28/2012 | US8124616 Bicyclic PPAT inhibitors as antibacterial agents |
02/28/2012 | US8124615 Diketo substituted pyrrolo[2,3-C]pyridines |
02/28/2012 | US8124614 Steroidal compounds for inhibiting steroid sulphatase |
02/28/2012 | US8124613 Spirotropane compounds |
02/28/2012 | US8124612 Treating neurological disorders using selective antagonists of persistent sodium current |
02/28/2012 | US8124611 Inhibitors of the mutant form of kit |
02/28/2012 | US8124610 Sodium channel inhibitors |
02/28/2012 | US8124609 Acyclic nucleoside derivatives |
02/28/2012 | US8124608 Mixture of disaccharides, polysaccharides and solvent |
02/28/2012 | US8124607 Poly aromatic pyrazinoylguanidine sodium channel blockers |
02/28/2012 | US8124606 Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-ones |
02/28/2012 | US8124605 Compositions and methods for modulating a kinase cascade |
02/28/2012 | US8124604 Inhibitors of bruton's tyrosine kinase |
02/28/2012 | US8124603 In vivo studies of crystalline forms of meloxicam |
02/28/2012 | US8124602 Compounds for the treatment of multi-drug resistant bacterial infections |
02/28/2012 | US8124601 Compounds for the treatment of Hepatitis C |
02/28/2012 | US8124599 Method for treating neuronal and non-neuronal pain |
02/28/2012 | US8124598 Administering 3-acetyl-7-oxo-dehydroepiandrosterone (7-keto DHEA) together with a carrier to treat to improve symptoms of depression, anxiety, bipolar, trauma; antiglucocorticoid; neuroprotective |
02/28/2012 | US8124597 Method of treating gaucher disease |
02/28/2012 | US8124596 Demethylpenclomedine analogs and their use as anti-cancer agents |
02/28/2012 | US8124595 Graduated estrogen contraceptive |
02/28/2012 | US8124594 Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels |
02/28/2012 | US8124593 Methods of treatment using sapacitabine |
02/28/2012 | US8124592 Development of a preventive vaccine for filovirus infection in primates |
02/28/2012 | US8124589 Use of ketogenic compounds for treatment of age-associated memory impairment |
02/28/2012 | US8124585 Composition for relieving discomfort |
02/28/2012 | US8124582 Treatment of diabetes |
02/28/2012 | US8124575 Polymeric surfactants based upon alkyl polyglycosides and sugars |
02/28/2012 | US8124371 Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation |
02/28/2012 | US8124134 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia |
02/28/2012 | US8124133 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect |
02/28/2012 | US8124130 Formulations and methods for recovery from dental surgery |
02/28/2012 | US8124129 Crystalline form of the compound A-348441 |
02/28/2012 | US8124128 For delivery of water insoluble drugs, growth factors, genes, or cosmetic substances; biocompatible and biodegradable |
02/28/2012 | US8124125 Solid dosage form comprising a fibrate |